Read More Pharma Industry News Zydus wins FDA nod for DMD drug Jaythari—what it means for rare disease treatment and its stock Find out how Zydus Lifesciences is expanding rare disease care and investor value with USFDA-approved Jaythari tablets for Duchenne muscular dystrophy. byPallavi MadhirajuApril 12, 2025